Open Access Article
Monica
Dell'Acqua
*a,
Valentina
Pirovano
a,
Giorgio
Confalonieri
a,
Antonio
Arcadi
b,
Elisabetta
Rossi
a and
Giorgio
Abbiati
*a
aDipartimento di Scienze Farmaceutiche – Sezione di Chimica Generale e Organica “A. Marchesini”, Università degli Studi di Milano, via G. Venezian, 21 – 20133 Milano, Italy. E-mail: monica.dellacqua@unimi.it; giorgio.abbiati@unimi.it
bDipartimento di Scienze Fisiche e Chimiche, Via Vetoio – 67010 L'Aquila, Italy
First published on 3rd September 2014
An easy entry to uncommon 2-propargylbenzaldehydes was developed. 2-Propargylbenzaldehydes demonstrated to be suitable building blocks for the synthesis of 3-benzyl isoquinolines by microwave promoted domino imination/cycloisomerisation in the presence of ammonium acetate. A small library of 3-benzyl isoquinolines was obtained in good yields under mild reaction conditions. Two alternative plausible reaction mechanisms are proposed.
For many years, we have been interested in the development of new sequential synthetic strategies for the construction of oxygen- or nitrogen-containing heterocycles starting from alkyne derivatives bearing a proximate carbonyl group. In particular, we have employed the addition/cycloisomerisation reactions of 2-alkynylbenzaldehydes (and their related heteroaromatic systems) in the presence of simple oxygen or nitrogen nucleophiles as useful tools to synthesise some interesting compounds such as isoquinolines,3 dihydroisobenzofurans,4 and isochromenes.5
Moreover, the domino approaches to dihydroisobenzofurans and isoquinolines have also been successfully transformed in two valuable Pd-catalysed multicomponent processes involving a one-pot coupling/addition/cyclisation sequence starting from simple building blocks, i.e., ortho-bromoarylaldehydes, terminal alkynes and a nucleophile, methanol6 or ammonia,7 respectively.
In order to extend the scope of our research, we have recently explored the reactivity of 2-alkynylacetophenones (keto-homologues of the 2-alkynylbenzaldehydes) and their pyridine analogues. We have found that the imination/annulation reactions of these less reactive substrates with ammonia needed a promoter, and silver triflate proved to be the preferred catalyst for these transformations, yielding the expected N-cyclisation products in addition to variable amounts of the isomeric carboannulation products.8
After having obtained these interesting results, we were intrigued by the idea of preparing some 2-propargylbenzaldehydes and to test their reactivity in the domino transformations described above. While the coupling of an alkynyl group in the ortho position of an ortho-haloarylaldehyde is a simple and well-known Pd-catalysed procedure, the introduction of a propargyl group in the same position is much more challenging, and only a few examples are reported in the literature.9 The most acknowledged approach was described by Eberbach and co-workers9a,b in 2000. The method includes five synthetic steps starting from the 2-bromobenzaldehyde. The first step of the approach involves the protection of the carbonyl group as a cyclic acetal, followed by a coupling reaction between the lithiated acetal derivative and the 3-bromo-1-(trimethylsilyl)-1-propyne. The triple bond is then deprotected by fluoride promoted desilylation, and functionalized by a Sonogashira coupling or by a base promoted nucleophilic substitution with methyl bromide. Finally, the acid promoted deprotection of the aldehyde gives the desired product. This is a useful and elegant method, and yet it presents some drawbacks: (1) the lithiation reaction is often a troublesome step requiring strictly controlled conditions; (2) the 3-bromo-1-(trimethylsilyl)-1-propyne is a rather expensive starting material; (3) the desilylation of the TMS-protected propargyl intermediate can experience scarce reproducibility (when fluoride promoted) or can give the isomeric allene (when base promoted).
Owing to the lack of general methods for the preparation of 2-propargyl arylaldehydes, the reactivity of these superior homologues of 2-alkynyl benzaldehydes has been less explored. For example, Eberbach and his co-workers have employed the 2-propargylbenzaldehydes as key-intermediates in the synthetic route to 2-propargylaryl nitrones, thus leading the way to the synthesis of the 1,2-dihydro[c]benzazepin-3-ones.9a,b On the other hand, Yamamoto's research group has documented the synthesis of important frameworks starting from these substrates. In 2010, they discovered an efficient metallic catalyst-free benzannulation with dialkylamines giving rise to various 2-dialkylaminonaphthalenes,10 and two years later they developed a smart synthetic approach to 2,3-dihydro-1H-inden-1-one derivatives through a Ni-catalysed intramolecular hydroacylation of 2-propargylbenzaldehydes.11
The 1-oxo-5-ynes are a class of related propargyl-based substrates, bearing a mandatory oxy group in the propargylic position. Liu and co-workers have described a highly stereoselective Au-catalysed synthesis of 9-oxabicyclo[3.3.1]nona-4,7-dienes from diverse 1-oxo-4-oxy-5-ynes.12 In 2013, a namesake of Liu (and his co-workers) proposed a new synthetic route to indeno[1,2-b]quinolones by reactions of 2-propargylbenzaldehydes with N-aryl amines based on an intramolecular aza-Diels–Alder (Povarov) reaction.13
In this work, we describe a general and effective approach to 2-propargylbenzaldehydes and their participation in microwave promoted domino addition/cycloisomerisation reactions in the presence of ammonia for the synthesis of 3-benzylisoquinolines (Scheme 1).
The isoquinoline nucleus is the core of various biologically active compounds, such as the alkaloid papaverine and the anaesthetic quinisocaine (Fig. 1). Saturated, functionalized and polycyclic isoquinolines show different important pharmacological properties;14 moreover, some simple 3-benzyl isoquinolines are also significantly active, and may be useful as lead compounds for developing potential chemotherapeutic agents. For example, some 1- and 3-benzylisoquinolines (e.g., 6,7-dimethoxy-3-veratryl-isoquinoline) and the corresponding quaternary salts have been tested for antimicrobial, antimalarial, cytotoxic, and anti-HIV activities.15 On top of this, the 3-benzylisoquinoline structure is the skeleton of some patented compounds, such as the PPAR-γ activity modulators16 proposed for the treatment of conditions such as type II diabetes and obesity, and the protein kinase inhibitors17 proposed for treating cancer, diabetes and Alzheimer's disease (Fig. 1).
| Entry | 1, 2 | R | t (h) step 1 | 1 Yielda (%) | t (h) step 2 | 2 Yielda (%) |
|---|---|---|---|---|---|---|
| a Yields refer to pure isolated products. b Yields after simple work-up. c Yields after column chromatography. d Yields after filtration on a short silica pad. | ||||||
| 1 | a | H | 1.0 | 99b | 2.0 | 81d |
| 2 | b | 4-Cl | 1.5 | 99b | 2.0 | 90d |
| 3 | c | 4-CH3 | 2.0 | 99b | 2.0 | 99d |
| 4 | d | 4-SO2CH3 | 3.0 | 77c | 2.0 | 57c |
| 5 | e | 3-CF3 | 2.0 | 99b | 2.5 | 59d |
| 6 | f | 2-C2H5 | 3.0 | 87c | 2.5 | 68c |
| 7 | g | 2-CH3, 3-Cl | 3.0 | 99c | 2.5 | 81d |
| 8 | h | 2-(i-Pr) | 2.0 | 95c | 2.0 | 85c |
The Sonogashira coupling did not seem to be strongly influenced by the nature of substituents on the phenyl ring; in fact, the yields of the reactions were in general very good for both electron-rich and electron-poor aryl iodides (entries 1–7). The presence of a group in the ortho-position of the aryl moiety was well tolerated too (entries 6–8). Conversely, in the bromination step, the presence of stronger EWGs on the aryl moiety gave low yields (entries 4 and 5).
We then optimised the coupling step between the 2-bromobenzaldehyde partner and the substituted propargyl bromides through a Grignard reaction: this allowed us to skip the annoying lithiation step described in the Eberbach approach. We protected the 2-bromobenzaldehyde and the 5-fluoro-2-bromobenzaldehyde as cyclic acetals by treating them with ethylene glycol and p-toluenesulfonic acid in toluene at reflux. Then, a stirred solution of properly protected benzaldehyde in anhydrous tetrahydrofuran and magnesium turnings was heated at 80 °C under a protective nitrogen atmosphere. Once the magnesium was almost completely dissolved, we slowly added the suitable substituted propargyl bromides 2a–h, and the reaction mixture was heated at 80 °C to give the 2-propargylbenzaldehyde acetals 3a–i. These intermediates were then hydrolysed to give the corresponding 2-propargylbenzaldehydes 4a–i by treatment with p-toluenesulfonic acid in a mixture of water and acetone at reflux (Scheme 2).
The key step of this procedure is the Grignard coupling reaction between 2-bromobenzaldehyde acetals and substituted propargyl bromides 2 (Table 2). The concentration of aryl bromide was found to be critical,20 and the best results were obtained using 1 M solution of the aryl bromide in tetrahydrofuran, while using a more diluted solution resulted in worse reproducibility and longer reaction times. The majority of the yields of the reactions ranged from fair to very good with all aryl propargyl bromides, while worse results were obtained in the presence of a methylsulfonyl group on arylalkyne terminus (entry 4), or of a fluorine atom on the benzaldehyde moiety (entry 9). In addition, the presence of a bulky group in the ortho position of the aryl iodide resulted in reduced yields (entry 8).
| Entry | 3, 4 | R1 | R2 | t (h) step 1 | 3 Yielda (%) | t (h) step 2 | 4 Yieldf (%) |
|---|---|---|---|---|---|---|---|
| a Yields refer to pure isolated products after flash column chromatography on a short silica gel column. b Under μW approach: reaction time, 50 min; yield, 70%. c Under μW approach: reaction time, 50 min; yield, 65%. d Under μW approach: reaction time, 50 min; yield, 64%. e Under μW approach: reaction time, 50 min; yield, 56%. f Yields refer to the pure isolated product after flash column chromatography. | |||||||
| 1 | a | H | H | 3.0 | 61b | 2.0 | 85 |
| 2 | b | H | 4-Cl | 3.0 | 81c | 2.0 | 94 |
| 3 | c | H | 4-CH3 | 3.0 | 68d | 2.0 | 96 |
| 4 | d | H | 4-SO2CH3 | 4.0 | 32 | 2.0 | 82 |
| 5 | e | H | 3-CF3 | 4.0 | 76e | 2.0 | 78 |
| 6 | f | H | 2-C2H5 | 4.0 | 79 | 2.0 | 89 |
| 7 | g | H | 2-CH3, 3-Cl | 4.0 | 77 | 3.0 | 89 |
| 8 | h | H | 2-(i-Pr) | 3.0 | 38 | 2.5 | 82 |
| 9 | i | F | 4-Cl | 5.5 | 54 | 3.0 | 78 |
We also explored the Grignard coupling step under microwave heating.21 Arylmagnesium species can be efficiently generated from magnesium turnings and aryl bromides (or chlorides) under dielectric heating.20 The reactions performed under dielectric heating were faster and the yields of 3 were comparable to those observed under traditional heating (see footnote entries 1–3 and 5). In the end, however, as the microwave approach presented some reproducibility problems we decided to choose conventional heating as the standard procedure, because this enabled an easier control of the reaction progress. The dioxolane intermediates 3 were not so stable, in particular at room temperature and in the presence of a slightly acidic solvent (i.e., deuterochloroform); therefore, after a quick 1H NMR and MS characterization, they were directly hydrolysed into the corresponding aldehydes 4 with yields ranging from good to excellent.
Having optimized an effective entry to 2-propargylbenzaldehydes 4, we then explored the reactivity of these starting materials to synthesise 3-benzylisoquinolines. At first, we screened the optimal reaction conditions on the 2-propargylbenzaldehyde 4b as a model substrate in the presence of methanolic ammonia3 (Table 3).
| Entry | Catalyst (mol%) | Energy – T (°C) | t (min) | 5b Yield (%) |
|---|---|---|---|---|
| a Yields calculated via1H NMR using dimethyl terephthalate (DMT) as an internal standard. b Yields refer to pure isolated products. | ||||
| 1 | — | μW – 100 | 10 | 36a |
| 2 | 4 Å mol. sieves | μW – 100 | 20 | 14a |
| 3 | AgOTf (10) | μW – 100 | 10 | 41b |
| 4 | AgOTf (10) | Oil bath – 60 | 360 | 51b |
| 5 | AgOTf (10) | μW – 100 | 10 | 48a |
| 6 | TiCl4 (50) | μW – 100 | 10 | 34a |
| 7 | TiCl2(Indenyl)2 (5) | μW – 100 | 10 | 47a |
| 8 | InCl3 (10) | μW – 100 | 20 | 49a |
| 9 | NaAuCl4 (5) | μW – 80 | 40 | 36a |
| 10 | AuCl3 (5) | μW – 100 | 50 | 46a |
| 11 | Au(PPh3)NTf2 (3) | μW – 100 | 10 | 42b |
We then ran the reaction under the conditions previously adopted for the addition/cycloisomerisation reactions of 2-alkynylbenzaldehydes (i.e., 20 equiv. of NH3).3 This uncatalysed reaction at 100 °C under microwave heating gave the corresponding isoquinoline 5b in low yield (entry 1). A tentative approach to promote the formation of the imine intermediate by the use of molecular sieves did not result in any improvement (entry 2). Based on our previous experience with 2-alkynylacetophenones,8 we planned to catalyse the reaction with AgOTf (10 mol%) both under dielectric and conventional heating conditions (entries 3–5). Under conventional heating the reaction yield raised to 51% in 6 h at 60 °C (entry 4), while under microwave heating at 100 °C the reaction gave almost the same yield in only 10 minutes (entry 5). Aiming to improve the yield, we tried some other metal catalysts potentially able to promote the reaction. Following the procedure previously optimised in our laboratory for the imination/annulation of 2-acetyl and 2-benzoyl N-propargylindoles22 and 2-acetyl-N-propargylpyrroles,3 we tried to catalyse the reaction with 0.5 equiv. of titanium tetrachloride, but these conditions gave poor yields (entry 6), while in the presence of a catalytic amount of TiCl2(indenyl)2 the desired product was obtained in 47% yield (entry 7). Using InCl3 as the catalyst gave comparable yield to the best results obtained in this screening (cf. entries 8, 4 and 5). We also tested some gold-based catalysts, well renowned as an alkynophilic Lewis acid, but the results were still unsatisfactory (entries 9–11).23
The homogeneous – but not completely satisfactory – results obtained under metal catalysis suggested that the tricky point of the approach was not the activation of the triple bond but, more probably, the nature of the nitrogen partner: this prompted us to try different ammonia sources.
In the existing literature, several ammonium salts are listed as alternative ammonia sources (e.g., (NH4)2CO3, NH4HCO3, HCO2NH4), and NH4OAc proved to be the most effective among them.24 Ammonium acetate is the salt of a weak acid (acetic acid) and a weak base (ammonia), and therefore it is easily decomposed by heat to AcOH and NH3. On top of this, ammonium acetate is a practical choice because it is an inexpensive and easy-to-handle solid. It has been employed only two times in the isoquinoline synthesis, that is in the cyclisation of 2-(1,1-difluoroalkenyl)-benzaldehyde25 and, more recently, in a Pd-catalysed multicomponent approach starting from 2-bromobenzaldehydes and terminal alkynes.26 However, the reactivity of the 2-propargylbenzaldehydes with ammonium acetate is unprecedented.
For this reason, we screened the optimal reaction conditions for the synthesis of 3-benzylisoquinolines with ammonium acetate as the ammonia source, and the results are shown in Table 4.
| Entry | NH4OAc | Solvent | T (°C) | 5b Yield (%) |
|---|---|---|---|---|
| a Yields calculated via1H NMR using dimethyl terephthalate (DMT) as an internal standard. | ||||
| 1 | 20 equiv. | EtOH | 120 | 68a |
| 2 | 20 equiv. | DMSO | 120 | 83a |
| 3 | 10 equiv. | DMSO | 120 | 79a |
| 4 | 20 equiv. | DMSO | 80 | 99 |
| 5 | 20 equiv. | H2O | 80 | — |
| 6 | 20 equiv. | H2O–EtOH (3 : 1) |
80 | — |
| 7 | 20 equiv. | H2O–DMSO (3 : 1) |
80 | — |
It has been reported that a large excess of NH4OAc is necessary for an effective ammonia generation,27 so the first experiment was performed with 20 equiv. of NH4OAc in ethanol at 120 °C under microwave irradiation. After 30 minutes, the reaction gave the desired product 5b in a promising 68% yield (entry 1). Then, we tried the reaction in DMSO27b and we were pleased to observe a good rise in yield (entry 2). The reduction of the amount of ammonium acetate to 10 equiv. gave only a modest reduction of the reaction yield (entry 3). Conversely, an excellent rise in yields was observed when we lowered the temperature (entry 4). Aiming to make the approach more environmentally-friendly, we tried to use water as the solvent (entry 5), but all our attempts were unsuccessful, also in the presence of EtOH or DMSO as co-solvents (entries 6 and 7).
Working under the best available conditions, we investigated the scope and the limitation of the approach. The results are shown in Table 5.
This microwave-enhanced protocol proved to be a general route for the synthesis of an array of isoquinolines in very good yields (entries 1–9). Both electron-donating and electron-withdrawing substituents were allowed on the phenyl group at alkynyl terminus (entries 1–5). The presence of a bulky substituent in the ortho position of the arylalkyne moiety did not seem to affect the reaction course (entries 6–8). Moreover, the presence of a fluorine group on the benzaldehyde moiety was also well tolerated (entry 9). All the reactions were clean and complete within 30 minutes, and the final products were easily and quickly purified by flash column chromatography. All the products have been fully characterized by 1H NMR and 13C NMR spectroscopy, as well as by MS spectrometry.
In accordance with our previous findings,28 we proposed a tentative reaction mechanism in which two different pathways are feasible (Scheme 3). The first step, the in situ formation of an imine intermediate (I) by reaction of 2-propargylbenzaldehydes 4 with the ammonia obtained by thermal cleavage of ammonium acetate, is common to both paths. To explain the cycloisomerisation step there are two conceivable pathways: (a) the triple bond undergoes a 6-exo-dig cyclisation directly by the imine, and the subsequent isomerisation leads to the formation of the final product 5; (b) the reaction conditions (heat and ammonia) promote the isomerisation of the triple bond to allene,29 thus allowing the intramolecular attack of the nucleophile on the central carbon of the allene framework30 with direct formation of the isoquinoline 5. On top of this, the regiospecificity observed is probably due to the resonance stabilization of the six-membered cyclisation product with respect to the alterative seven-membered one. As proof of that, the 7-endo-dig cyclisation mode is quite uncommon in the literature (c).31
:
5). After cooling to room temperature, the mixture was concentrated under reduced pressure, poured in a HCl 0.1 N aq. solution (60 mL) and extracted with diethyl ether (3 × 40 mL). The organic layers were dried over Na2SO4 and the solvent was removed under reduced pressure. Unless otherwise stated, the compounds were used without the need for chromatographic purification.
:
5). Yield: 971 mg (77%). Light brown solid. Mp 81–82 °C. 1H NMR (200 MHz, CDCl3): δ = 2.41 (bs, 1H, OH), 3.04 (s, 3H, CH3), 4.49 (s, 2H, CH2), 7.53 (d, J = 8.1 Hz, 2H, HAr), 7.85 (d, J = 8.1 Hz, 2H, HAr). 13C NMR (50.3 MHz, CDCl3): δ = 44.6 (CH3), 51.5 (CH2), 83.9 (Csp), 91.9 (Csp), 127.5 (CHAr), 128.8 (Cq), 132.6 (CHAr), 140.0 (Cq). ESI-MS m/z (%): 211.2 (45) [M + H]+, 233.1 (60) [M + Na]+, 242 (100) [M + CH3OH + H]+. HRMS ESI [M + H]+ calcd for C10H11O3S 211.0423, found 211.424.
:
1). Yield: 836 mg (87%). Light yellow oil. 1H NMR (200 MHz, CDCl3): δ = 1.24 (t, J = 7.5 Hz, 3H, CH3), 1.81 (bs, 1H, OH), 2.80 (q, J = 7.5 Hz, 2H, CH2), 4.54 (s, 2H, CH2), 7.09–7.31 (m, 3H, HAr), 7.41 (d, J = 7.5 Hz, 1H, HAr). 13C NMR (50.3 MHz, CDCl3): δ = 15.0 (CH3), 27.8 (CH2), 52.0 (CH2), 84.6 (Csp), 90.8 (Csp), 121.8 (Cq), 125.8 (CHAr), 128.1 (CHAr), 128.9 (CHAr), 132.6 (CHAr), 146.5 (Cq). ESI-MS m/z (%): 301 (52) [dimer − H2 − H2O + H]+, 303 (32) [dimer − H2O + H]+, 339 (100) [dimer + H2O + H]+. HRMS ESI [M + H]+ calcd for C11H13O 161.0961, found 161.0959.
:
1). Yield: 1.07 g (99%). Light brown solid. Mp: 54–59 °C. 1H NMR (200 MHz, CDCl3): δ = 1.71 (bs, 1H, OH), 2.50 (s, 3H, CH3), 4.54 (s, 2H, CH2), 7.06 (t, J = 7.9 Hz, 1H, HAr), 7.32 (d, J = 7.9 Hz, 2H, HAr). 13C NMR (50.3 MHz, CDCl3): δ = 18.5 (CH3), 51.8 (CH2), 84.2 (Csp), 91.9 (Csp), 124.5 (Cq), 126.7 (CHAr), 129.7 (CHAr), 130.9 (CHAr), 134.9 (Cq), 138.3 (Cq). ESI-MS m/z (%): 145.1 (50) [M − Cl]+, 164.8 (100) [M − H2O + H]+, 180.9 (75) [M + H]+. HRMS ESI [M + H]+ calcd for C10H10ClO 181.0415, found 181.0413.
:
1). Yield: 994 mg (95%). Brown oil. 1H NMR (200 MHz, CDCl3): δ = 1.25 (d, J = 7.0 Hz, 6H, CH3), 3.44 (sept, J = 7.0 Hz, 1H, CH), 4.54 (s, 2H, CH2), 7.08–7.17 (m, 1H, HAr), 7.26–7.30 (m, 2H, HAr), 7.41 (d, J = 7.3 Hz, 1H, HAr). 13C NMR (50.3 MHz, CDCl3): δ = 23.4 (CH3), 31.7 (CH), 51.9 (CH2), 84.6 (Csp), 91.1 (Csp), 121.5 (Cq), 125.2 (CHAr), 125.7 (CHAr), 129.1 (CHAr), 132.8 (CHAr), 150.8 (Cq). ESI-MS m/z (%): 174.2 (10) [M]+, 234.4 (100) [M + AcOH]+. HRMS ESI [M + H]+ calcd for C12H15O 175.1117, found 175.1119.
:
1). Hexane (130 mL) was added to precipitate the phosphine oxide and the white suspension was passed through a short silica pad (3 cm diameter × 2 cm height) and washed with hexane. The crude product was freed from solvents under reduced pressure. Unless otherwise stated, the compounds were used without the need of chromatographic purification.
:
4). Yield: 1.94 g (57%). Brown solid. Mp: 98–102 °C. 1H NMR (200 MHz, CDCl3): δ = 3.05 (s, 3H, CH3), 4.15 (s, 2H, CH2), 7.60 (d, J = 8.6 Hz, 2H, HAr), 7.88 (d, J = 8.6 Hz, 2H, HAr). 13C NMR (50.3 MHz, CDCl3): δ = 14.4 (CH2), 44.6 (CH3), 84.8 (Csp), 88.4 (Csp), 127.6 (CHAr), 128.2 (Cq), 132.8 (CHAr), 140.6 (Cq). ESI-MS m/z (%): 217.3 (100) [M − Br + Na]+, 273.2/275.1 (18) [M + H]+, 295.0/297.1 (31) [M + Na]+. HRMS ESI [M + H]+ calcd for C10H10BrO2S 272.9579, found 272.9581.
:
1). Yield: 1.90 g (68%). Light yellow oil. 1H NMR (200 MHz, CDCl3): δ = 1.25 (t, J = 7.6 Hz, 3H, CH3), 2.80 (q, J = 7.6 Hz, 2H, CH2), 4.21 (s, 2H, CH2), 7.07–7.34 (m, 3H, HAr), 7.41 (dd, J = 7.4, 1.1 Hz, 1H, HAr). 13C NMR (50.3 MHz, CDCl3): δ = 15.1 (CH3), 15.7 (CH2), 27.8 (CH2), 86.0 (Csp), 87.7 (Csp), 121.5 (Cq), 125.8 (CHAr), 128.2 (CHAr), 129.3 (CHAr), 132.7 (CHAr), 147.0 (Cq). ESI-MS m/z (%): 143.1 (75) [M − Br]+, 447 (100) [dimer + H]+. HRMS ESI [M + H]+ calcd for C11H12Br 223.0117, found 223.0120.
:
1). Yield: 2.52 g (85%). Light brown oil. 1H NMR (200 MHz, CDCl3): δ = 1.26 (d, J = 7.0 Hz, 6H, CH3), 3.41 (sept, J = 7.0 Hz, 1H, CH), 4.21 (s, 2H, CH2), 7.09–7.17 (m, 1H, HAr), 7.26–7.32 (m, 2H, HAr), 7.40 (d, J = 7.3 Hz, 1H, HAr).13C NMR (50.3 MHz, CDCl3): δ = 15.8 (CH2), 23.3 (CH3), 31.8 (CH), 86.0 (Csp), 87.9 (Csp), 121.1 (Cq), 125.2 (CHAr), 125.7 (CHAr), 129.4 (CHAr), 132.8 (CHAr), 151.3 (Cq). ESI-MS m/z (%): 157.4 (100) [M − Br]+. HRMS ESI [M + H]+ calcd for C12H14Br 237.0273, found 237.0277.
:
5). Yield: 3.02 g (91%). Colourless oil. 1H NMR (200 MHz, CDCl3): δ = 4.05–4.10 (m, 2H, O-CH2), 4.13–4.18 (m, 2H, O-CH2), 6.10 (s, 1H, CH), 7.20 (dt, J = 7.3, 1.8 Hz, 1H, HAr), 7.34 (dt, J = 7.5, 1.4 Hz, 1H, HAr), 7.58 (dt, J = 7.5, 1.6 Hz, 2H, HAr). These data are in good agreement with literature values.38
:
1). Yield: 2.83 g (79%). Colourless oil. 1H NMR (200 MHz, CDCl3): δ = 4.03–4.10 (m, 2H, O-CH2), 4.13–4.20 (m, 2H, O-CH2), 6.04 (s, 1H, CH), 6.95 (tdd, J = 8.5, 3.1, 0.6 Hz, 1H, HAr), 7.33 (dd, J = 3.1, 9.3 Hz, 1H, HAr) 7.52 (dd, J = 5.1, 8.7 Hz, 1H, HAr). 13C NMR (50.3 MHz, CDCl3): δ = 65.8 (CH2), 102.2 (d, 4JC–F = 1.1 Hz, CH), 115.3 (d, 2JC–F = 24.4 Hz, CHAr), 117.0 (d, 4JC–F = 3.0 Hz, Cq), 117.9 (d,2JC–F = 22.9 Hz, CHAr), 134.5 (d, 3JC–F = 7.6 Hz, CHAr), 139.2 (d, 3JC–F = 6.9 Hz, Cq), 162.2 (d, 1JC–F = 247 Hz, C–F). ESI-MS m/z (%): 247.2/245.2 (100) [M]+. HRMS ESI [M + H]+ calcd for C9H9BrFO2 246.9764, found 246.9761.
:
1). Yield: 0.32 g (61%). Light brown oil. 1H NMR (200 MHz, CDCl3): δ = 4.01 (s, 2H, CH2), 4.04–4.10 (m, 2H, O-CH2), 4.11–4.17 (m, 2H, O-CH2), 6.07 (s, 1H, CH), 7.22–7.50 (m, 7H, HAr), 7.53–7.71 (m, 2H, HAr). These data are in good agreement with literature values.9a
:
1). Yield: 0.48 g (81%). Light yellow oil. 1H NMR (200 MHz, CDCl3): δ = 3.99 (s, 2H, CH2), 4.05–4.09 (m, 2H, O-CH2), 4.12–4.16 (m, 2H, O-CH2), 6.05 (s, 1H, CH), 7.24–7.38 (m, 6H, HAr), 7.61 (m, 2H, HAr). ESI-MS m/z (%): 299.2 (100) [M + H]+.
:
1). Yield: 0.39 g (68%). Dark yellow oil. 1H NMR (200 MHz, CDCl3): δ = 2.34 (s, 3H, CH3), 3.99 (s, 2H, CH2), 4.04–4.10 (m, 2H, O-CH2), 4.17–4.10 (m, 2H, O-CH2), 6.07 (s, 1H, CH), 7.06–7.15 (m, 2H, HAr), 7.27–7.43 (m, 4H, HAr), 7.52–7.69 (m, 2H, HAr). ESI-MS m/z (%): 279.3 (100) [M + H]+. These data are in good agreement with literature values.9a
:
3). Yield: 0.22 g (32%). Light brown oil. 1H NMR (200 MHz, CDCl3): δ = 3.04 (s, 3H, CH3), 4.03 (s, 2H, CH2), 4.04–4.11 (m, 2H, O-CH2), 4.11–4.18 (m, 2H, O-CH2), 6.04 (s, 1H, CH), 7.28–7.48 (m, 3H, HAr), 7.53–7.65 (m, 3H, HAr), 7.87 (d, J = 8.5 Hz, 2H, HAr). ESI-MS m/z (%): 343.5 (100) [M + H]+.
:
1). Yield: 0.51 g (76%). Yellow oil. 1H NMR (200 MHz, CDCl3): δ = 4.01 (s, 2H, CH2), 4.05–4.11 (m, 2H, O-CH2), 4.12–4.18 (m, 2H, O-CH2), 6.06 (s, 1H, CH), 7.29–7.63 (m, 7H, HAr), 7.70 (s, 1H, HAr). ESI-MS m/z (%): 333.2 (100) [M + H]+.
:
1). Yield: 0.46 g (79%). Yellow oil. 1H NMR (200 MHz, CDCl3): δ = 1.25 (t, J = 7.6 Hz, 3H, CH3), 2.83 (q, J = 7.6 Hz, 2H, CH2), 4.05 (s, 2H, CH2), 4.06–4.10 (m, 2H, O-CH2), 4.11–4.18 (m, 2H, O-CH2), 6.07 (s, 1H, CH), 7.07–7.24 (m, 3H, HAr), 7.27–7.47 (m, 3H, HAr), 7.58 (dd, J = 1.8, 7.3 Hz, 1H, HAr), 7.63–7.72 (m, 1H, HAr). ESI-MS m/z (%): 293.2 (100) [M + H]+, 263 (20) [M − CH2CH3]+.
:
1). Yield: 0.48 g (77%). Yellow oil. 1H NMR (200 MHz, CDCl3): δ = 2.51 (s, 3H, CH3), 4.05 (s, 2H, CH2), 4.06–4.11 (m, 2H, O-CH2), 4.12–4.17 (m, 2H, O-CH2), 6.06 (s, 1H, CH), 7.04 (t, J = 7.8 Hz, 1H, HAr), 7.28–7.44 (m, 4H, HAr), 7.58 (dd, J = 1.9, 7.3 Hz, 1H, HAr), 7.63 (dd, J = 1.0, 7.2 Hz, 1H, HAr). ESI-MS m/z (%): 313.1 (100) [M + H]+.
:
1). Yield: 0.23 g (38%). Brown oil. 1H NMR (200 MHz, CDCl3): δ = 1.25 (d, J = 7.0 Hz, 6H, CH3), 3.48 (sept, J = 7.0 Hz, 1H, CH), 4.05 (s, 2H, CH2), 4.02–4.11 (m, 2H, O-CH2), 4.12–4.17 (m, 2H, O-CH2), 6.07 (s, 1H, CH), 7.07–7.16 (m, 1H, HAr), 7.24–7.29 (m, 2H, HAr), 7.32–7.41 (m, 2H, HAr), 7.42–7.51 (m, 1H, HAr), 7.58 (dd, J = 1.8, 7.4 Hz, 1H, HAr), 7.67 (d, J = 7.1 Hz, 1H, HAr). ESI-MS m/z (%): 307.2 (100) [M + H]+.
:
1). Yield: 0.34 g (54%). Light yellow oil. 1H NMR (200 MHz, CDCl3): δ = 3.92 (s, 2H, CH2), 4.00–4.09 (m, 2H, O-CH2), 4.10–4.21 (m, 2H, O-CH2), 6.03 (s, 1H, CH), 6.99–7.18 (m, 2H, HAr), 7.21–7.42 (m, 4H, HAr), 7.54 (dd, J = 5.5, 8.5 Hz, 1H, HAr). ESI-MS m/z (%): 317.4 (100) [M + H]+.
:
1 (10 mL). The mixture was refluxed until completion of the reaction (2–3 h), detectable by TLC analysis (eluent: hexane–ethyl acetate 9
:
1). After cooling to rt, satd aqueous NaHCO3 (40 mL) was added and the solution was extracted with diethyl ether (20 × 3). The combined organic phases were washed with brine (30 mL), dried over Na2SO4 and the solvent was removed at reduced pressure. The residue was purified by flash chromatography, affording the desired 2-propargylbenzaldehydes 4a–i.
:
1). Yield: 280 mg (85%). Yellow oil. 1H NMR (200 MHz, CDCl3): δ = 4.30 (s, 2H, CH2), 7.27–7.34 (m, 3H, HAr), 7.38–7.53 (m, 3H, HAr), 7.54–7.67 (m, 1H, HAr), 7.74–7.90 (m, 2H, HAr), 10.28 (s, 1H, CHO). These data are in good agreement with literature values.9a
:
1). Yield: 359 mg (94%). Light yellow solid. Mp: 64–68 °C. 1H NMR (200 MHz, CDCl3): δ = 4.29 (s, 2H, CH2), 7.27 (d, J = 8.7 Hz, 2H, HAr), 7.37 (d, J = 8.6 Hz, 2H, HAr), 7.48 (dt, J = 7.4, 1.3 Hz, 1H, HAr), 7.61 (dt, J = 1.5, 7.5 Hz, 1H, HAr), 7.76 (d, J = 7.6 Hz, 1H, HAr), 7.84 (dd, J = 1.4, 7.5 Hz, 1H, HAr), 10.26 (s, 1H, CHO). 13C NMR (50.3 MHz, CDCl3): δ = 23.8 (CH2), 83.0 (Csp), 88.0 (Csp), 122.2 (Cq), 127.7 (CHAr), 128.8 (CHAr), 130.2 (CHAr), 133.1 (CHAr), 133.5 (Cq), 134.0 (CHAr), 134.2 (Cq), 134.3 (CHAr), 138.6 (Cq), 192.9 (CHO). ESI-MS m/z (%): 255.0 (100) [M + H]+. HRMS ESI [M + H]+ calcd for C16H12ClO2 255.0571, found 255.0572.
:
1). Yield: 337 mg (96%). Orange oil. 1H NMR (200 MHz, CDCl3): δ = 2.34 (s, 3H, CH3), 4.29 (s, 2H, CH2), 7.11 (d, J = 7.9 Hz, 2H, HAr), 7.34 (d, J = 8.0 Hz, 2H, HAr), 7.47 (m, 1H, HAr), 7.61 (dt, J = 1.5, 7.5 Hz, 1H, HAr), 7.82 (dt, J = 7.7, 1.4 Hz, 2H, HAr), 10.28 (s, 1H, CHO). These data are in good agreement with literature values.9a
:
2). Yield: 367 mg (82%). Yellow oil. 1H NMR (200 MHz, CDCl3): δ = 3.03 (s, 3H, CH3), 4.37 (s, 2H, CH2), 7.49 (dt, J = 1.0, 7.3 Hz, 1H, HAr), 7.59 (d, J = 8.4 Hz, 2H, HAr), 7.57–7.67 (m, 1H, HAr), 7.72 (d, J = 7.4 Hz, 1H, HAr), 7.80–7.84 (m, 1H, HAr), 7.86 (d, J = 8.5 Hz, 2H, HAr), 10.22 (s, 1H, CHO). 13C NMR (50.3 MHz, CDCl3): δ = 23.8 (CH2), 44.7 (CH3), 82.4 (Csp), 91.7 (Csp), 127.5 (CHAr), 127.9 (CHAr), 129.6 (Cq), 130.2 (CHAr), 132.6 (CHAr), 133.5 (Cq), 134.3 (CHAr), 134.4 (CHAr), 137.9 (Cq), 139.7 (Cq). ESI-MS m/z (%): 619.0 (100) [dimer + Na]+, 321.3 (40) [M + Na]+. HRMS ESI [M + H]+ calcd for C17H15O3S 299.0736, found 299.0732.
:
1). Yield: 337 mg (78%). Pale yellow solid. Mp: 42–46 °C. 1H NMR (200 MHz, CDCl3): δ = 4.32 (s, 2H, CH2), 7.34–7.97 (m, 8H, HAr), 10.25 (s, 1H, CHO). 13C NMR (50.3 MHz, CDCl3): δ = 23.4 (CH2), 82.6 (Csp), 88.8 (Csp), 123.9 (q, 1JC–F = 272.0 Hz, CF3), 124.1 (Cq), 124.6 (CHAr), 124.7 (q, 3JC–F = 3.8 Hz, CHAr), 128.6 (q, 3JC–F = 3.8, CHAr), 129.0 (CHAr), 130.2 (CHAr), 131.1 (q, 2JC–F = 32.0 Hz, Cq), 133.5 (Cq), 134.3 (CHAr), 135.0 (CHAr), 138.3 (Cq), 193.1 (CHO). ESI-MS m/z (%): 289.4 (100) [M + H]+. HRMS ESI [M + H]+ calcd for C17H12F3O 289.0835, found 289.0834.
:
1). Yield: 331 mg (89%). Yellow oil. 1H NMR (200 MHz, CDCl3): δ = 1.23 (t, J = 7.6 Hz, 3H, CH3), 2.80 (q, J = 7.5 Hz, 2H, CH2), 4.35 (s, 2H, CH2), 7.04–7.30 (m, 3H, HAr), 7.38–7.53 (m, 2H, HAr), 7.61 (dt, J = 1.6, 7.5 Hz, 1H, HAr), 7.83 (dt, J = 7.2, 1.5 Hz, 2H, HAr), 10.28 (s, 1H, CHO). 13C NMR (50.3 MHz, CDCl3): δ = 15.1 (CH3), 23.9 (CH2), 28.0 (CH2), 82.9 (Csp), 90.3 (Csp), 122.8 (Cq), 125.8 (CHAr), 127.5 (CHAr), 128.1 (CHAr), 128.4 (CHAr), 130.2 (CHAr), 132.5 (CHAr), 133.5 (Cq), 133.7 (CHAr), 134.2 (CHAr), 139.2 (Cq), 146.4 (Cq), 192.9 (CHO). ESI-MS m/z (%): 263.3 (100) [M + CH3]+, 249.2 (30) [M + H]+. HRMS ESI [M + H]+ calcd for C18H17O 249.1274, found 249.1277.
:
1). Yield: 358 mg (89%). Pale yellow solid. Mp: 90–94 °C. 1H NMR (200 MHz, CDCl3): δ = 2.50 (s, 3H, CH3), 4.35 (s, 2H, CH2), 7.05 (t, J = 7.8 Hz, 1H, HAr), 7.31 (m, 2H, HAr), 7.49 (dt, J = 1.2, 7.4 Hz, 1H, HAr), 7.62 (dt, J = 1.6, 7.5 Hz, 1H, HAr), 7.78 (d, J = 7.6 Hz, 1H, HAr), 7.85 (dd, J = 1.6, 7.4 Hz, 1H, HAr), 10.26 (s, 1H, CHO). 13C NMR (50.3 MHz, CDCl3): δ = 18.5 (CH3), 23.9 (CH2), 82.9 (Csp), 91.5 (Csp), 125.4 (Cq), 126.6 (CHAr), 127.6 (CHAr), 129.2 (CHAr), 130.1 (CHAr), 130.1 (CHAr), 130.8 (CHAr), 133.5 (Cq), 134.1 (CHAr), 134.3 (CHAr), 134.9 (Cq), 138.2 (Cq), 138.8 (Cq), 193.0 (CHO). ESI-MS m/z (%): 269.3 (100) [M + H]+. HRMS ESI [M + H]+ calcd for C17H14ClO 269.0728, found 269.0725.
:
1). Yield: 322 mg (82%). Light yellow oil. 1H NMR (200 MHz, CDCl3): δ = 1.24 (d, J = 7.0 Hz, 6H, CH3), 3.45 (sept, J = 7.0 Hz, 1H, CH), 4.35 (s, 2H, CH2), 7.08–7.16 (m, 1H, HAr), 7.24–7.28 (m, 2H, HAr), 7.41–7.45 (m, 2H, HAr), 7.49 (dd, J = 1.1, 7.3 Hz, 1H, HAr), 7.61 (dt, J = 1.5, 7.3 Hz, 1H, HAr), 7.83 (dt, J = 1.5, 7.3 Hz, 1H, HAr), 10.29 (s, 1H, CHO). 13C NMR (50.3 MHz, CDCl3): δ = 23.3 (CH3), 24.0 (CH2), 31.7 (CH), 83.0 (Csp), 90.5 (Csp), 122.5 (Cq), 125.1 (CHAr), 125.7 (CHAr), 127.5 (CHAr), 128.6 (CHAr), 130.2 (CHAr), 132.7 (CHAr), 133.6 (Cq), 133.7 (CHAr), 134.2 (CHAr), 139.2 (Cq), 150.6 (Cq), 192.9 (CHO). ESI-MS m/z (%): 285.2 (100) [M + Na]+, 263.3 (10) [M + H]+. HRMS ESI [M + H]+ calcd for C19H19O 263.1430, found 263.1428.
:
1). Yield: 317 mg (78%). White solid. Mp: 65 °C. 1H NMR (200 MHz, CDCl3): δ = 4.21 (s, 2H, CH2), 7.22–7.39 (m, 5H, HAr), 7.54 (dd, J = 2.8, 8.5 Hz, 1H, HAr), 7.70 (dd, J = 5.1, 8.5 Hz, 1H, HAr), 10.25 (d, JH–F = 1.2 Hz 1H, CHO). 13C NMR (50.3 MHz, CDCl3): δ = 23.0 (CH2), 83.1 (Csp), 87.7 (Csp), 119.1 (d, 2JC–F = 22.1 Hz, CHAr), 121.2 (d, 2JC–F = 21.0 Hz, CHAr), 121.9 (Cq), 128.8 (CHAr), 132.2 (d, 3JC–F = 7.2 Hz, CHAr), 133.1 (CHAr), 134.4 (Cq), 134.5 (d, 4JC–F = 3.4 Hz, Cq). 135.0 (d, 3JC–F = 5.7 Hz, Cq), 162.1 (d, 1JC–F = 248 Hz, C–F), 191.1 (d, 4JC–F = 1.5 Hz, CHO). ESI-MS m/z (%): 532.2 (100) [dimer + Na − Cl]+. HRMS ESI [M + H]+ calcd for C16H11ClFO 273.0477, found 273.0479.
:
5). Yield: 55 mg (78%). Red solid. Mp: 60–61 °C. 1H NMR (CDCl3, 200 MHz): δ = 4.33 (s, 2H, CH2), 7.21–7.29 (m, 1H, HAr), 7.32–7.34 (m, 4H, HAr), 7.43 (s, 1H, HAr), 7.53 (dt, J = 6.6, 1.5 Hz, 1H, HAr), 7.63 (dt, J = 6.6, 1.5 Hz, 1H, HAr), 7.72 (d, J = 7.7 Hz, 1H, HAr), 7.93 (d, J = 7.3 Hz, 1H, HAr), 9.22 (s, 1H, HAr). 13C NMR (CDCl3, 50.3 MHz): δ = 44.6 (CH2), 118.9 (CHAr), 126.5 (CHAr), 126.6 (CHAr), 126.8 (CHAr), 127.4 (Cq), 127.7 (CHAr), 128.8 (CHAr), 129.5 (CHAr), 130.5 (CHAr), 136.8 (Cq), 140.1 (Cq), 152.6 (CHAr), 154.7 (Cq). ESI-MS m/z (%): 220.3 (100) [M + H]+. HRMS ESI [M + H]+ calcd for C16H14N 220.1121, found 220.1123.
:
5). Yield: 71 mg (93%). Light brown solid. Mp: 78–80 °C. 1H NMR (200 MHz, CDCl3): δ = 4.27 (s, 2H, CH2), 7.16–7.34 (m, 4H, HAr), 7.42 (s, 1H, HAr), 7.48–7.63 (m, 1H, HAr), 7.67 (dd, J = 1.3, 6.6 Hz, 1H, HAr), 7.73 (d, J = 8.1 Hz, 1H, HAr), 7.94 (d, J = 8.0 Hz, 1H, HAr), 9.21 (s, 1H, HAr). 13C NMR (50.3 MHz, CDCl3): δ = 43.6 (CH2), 119.1 (CHAr), 126.49 (CHAr), 127.1 (CHAr), 127.4 (Cq), 127.8 (CHAr), 128.9 (CHAr), 130.8 (CHAr), 130.9 (CHAr), 132.5 (Cq), 136.8 (Cq), 138.4 (Cq), 152.4 (CHAr), 153.8 (Cq). ESI-MS m/z (%): 254.3 (100) [M + H]+. HRMS ESI [M + H]+ calcd for C16H13ClN 254.0731, found 254.0730.
:
5). Yield: 55 mg (74%). Brown solid. Mp: 55–59 °C. 1H NMR (200 MHz, CDCl3): δ = 2.33 (s, 3H, CH3), 4.28 (s, 2H, CH2), 7.13 (d, J = 8.1 Hz, 2H, HAr), 7.22 (d, J = 8.1 Hz, 2H, HAr), 7.42 (s, 1H, HAr), 7.47–7.57 (m, 1H, HAr), 7.58–7.68 (m, 1H, HAr), 7.71 (d, J = 7.6 Hz, 1H, HAr), 7.93 (d, J = 7.5 Hz, 1H, HAr), 9.21 (s, 1H, HAr). 13C NMR (50.3 MHz, CDCl3): δ = 21.3 (CH3), 44.0 (CH2), 118.9 (CHAr), 126.5 (CHAr), 126.8 (CHAr), 127.3 (Cq), 127.8 (CHAr), 129.3 (CHAr), 129.5 (CHAr), 130.6 (CHAr), 136.1 (Cq), 136.9 (Cq), 152.3 (CHAr), 154.8 (Cq). ESI-MS m/z (%): 234.3 (100) [M + H]+. HRMS ESI [M + H]+ calcd for C17H16N 234.1277, found 224.1275.
:
4). Yield: 64 mg (67%). Light brown oil. 1H NMR (200 MHz, CDCl3): δ = 3.01 (s, 3H, CH3), 4.37 (s, 2H, CH2), 7.50 (m, 3H, HAr), 7.54–7.79 (m, 3H, HAr), 7.86 (d, J = 8.1 Hz, 2H, HAr), 7.94 (m, 1H, HAr), 9.20 (s, 1H, HAr). 13C NMR (50.3 MHz, CDCl3): δ = 44.3 (CH2), 44.8 (CH3), 119.4 (CHAr), 126.5 (CHAr), 127.3 (CHAr), 127.6 (Cq), 127.8 (CHAr), 127.9 (CHAr), 130.3 (CHAr), 130.9 (CHAr), 136.71 (Cq), 138.8 (Cq), 146.7 (Cq), 152.8 (Cq), 152.9 (CHAr). ESI-MS m/z (%): 298.3 (100) [M + H]+. HRMS ESI [M + H]+ calcd for C17H16NO2S 298.0896, found 298.0898.
:
5). Yield: 74 mg (81%). Brown solid. Mp: 60–65 °C. 1H NMR (200 MHz, CDCl3): δ = 4.36 (s, 2H, CH2), 7.36–7.61 (m, 5H, HAr), 7.61–7.72 (m, 2H, HAr), 7.75 (m, 1H, HAr), 7.95 (m, 1H, HAr), 9.24 (s, 1H, HAr). 13C NMR (50.3 MHz, CDCl3): δ = 44.2 (CH2), 119.2 (CHAr), 124.6 (q, 1JC–F = 272.0 Hz, CF3), 123.5 (q, 3JC–F = 3.8 Hz, CHAr), 126.1 (q, 3JC–F = 3.8 Hz, CHAr), 126.5 (CHAr), 127.1 (CHAr), 127.5 (Cq), 127.8 (CHAr), 129.2 (CHAr), 130.8 (CHAr), 132.8 (CHAr), 136.8 (Cq), 140.9 (Cq), 152.7 (CHAr), 153.4 (Cq) (one Cq obscured). ESI-MS m/z (%): 288.4 (100) [M + H]+. HRMS ESI [M + H]+ calcd for C17H13F3N 288.0995, found 288.0992.
:
2). Yield: 56 mg (71%). Brown oil. 1H NMR (200 MHz, CDCl3): δ = 1.17 (t, J = 7.5 Hz, 3H, CH3), 2.68 (q, J = 7.5 Hz, 2H, CH2), 4.39 (s, 2H, CH2), 7.16–7.31 (m, 5H, HAr), 7.48–7.57 (m, 1H, HAr), 7.51–7.61 (m, 1H, HAr), 7.63–7.66 (m, 1H, HAr), 7.94 (dd, J = 7.9, 0.6 Hz, 1H, HAr), 9.23 (s, 1H, HAr). 13C NMR (50.3 MHz, CDCl3): δ = 15.2 (CH3), 26.1 (CH2), 41.6, (CH2), 118.5 (CHAr), 126.3 (CHAr), 126.5 (CHAr), 126.8 (CHAr), 127.2 (CHAr), 127.7 (Cq), 128.8 (CHAr), 130.5 (CHAr), 130.9 (CHAr), 136.7 (Cq), 137.2 (Cq), 143.0 (Cq), 152.4 (CHAr), 154.9 (Cq). ESI-MS m/z (%): 248.3 (100) [M + H]+, 270.1 (22) [M + Na]+. HRMS ESI [M + H]+ calcd for C18H18N 248.1434, found 248.1434.
:
5). Yield: 71 mg (83%). Brown solid. Mp: 58–60 °C. 1H NMR (200 MHz, CDCl3): δ = 2.33 (s, 3H, CH3), 4.37 (s, 2H, CH2), 7.12–7.15 (m, 2H, HAr), 7.21 (s, 1H, HAr), 7.26–7.34 (m, 1H, HAr), 7.50–7.70 (m, 3H, HAr), 7.89–8.00 (dd, J = 1.1, 8.4 Hz, 1H, HAr), 9.23 (s, 1H, HAr). 13C NMR (50.3 MHz, CDCl3): δ = 16.6 (CH3), 43.0 (CH2), 118.5 (CHAr), 126.5 (CHAr), 126.9 (CHAr), 127.4 (Cq), 127.7 (CHAr), 128.1 (CHAr), 129.2 (CHAr), 130.6 (CHAr), 135.3 (Cq), 135.5 (Cq), 136.7 (Cq), 140.0 (Cq), 152.5 (CHAr), 153.7 (Cq). ESI-MS m/z (%): 268.3 (100) [M + H]+. HRMS ESI [M + H]+ calcd for C17H15ClN 268.0888, found 268.0888.
:
5). Yield: 63 mg (76%). Light brown solid. Mp: 62–64 °C. 1H NMR (200 MHz, CDCl3): δ = 1.16 (d, J = 7.0 Hz, 6H, CH3), 3.22 (sept, J = 7.0 Hz, 1H, CH), 4.43 (s, 2H, CH2), 7.19–7.40 (m, 5H, HAr), 7.47–7.55 (m, 1H, HAr), 7.60–7.66 (m, 2H, HAr), 7.94 (m, 1H, HAr), 9.24 (s, 1H, HAr). 13C NMR (50.3 MHz, CDCl3): δ = 24.0 (CH3), 29.4 (CH), 41.8 (CH2), 118.5 (CHAr), 125.9 (CHAr), 126.1 (CHAr), 126.5 (CHAr), 126.7 (CHAr), 127.3 (Cq), 127.5 (CHAr), 127.7 (CHAr), 130.5 (CHAr), 131.1 (CHAr), 136.4 (Cq), 136.7 (Cq), 147.8 (Cq), 152.3 (CHAr), 155.2 (Cq). ESI-MS m/z (%): 262.3 (100) [M + H]+. HRMS ESI [M + H]+ calcd for C19H20N 262.1590, found 262.1593.
:
5). Yield: 62 mg (71%). Brown oil. 1H NMR (200 MHz, CDCl3): δ = 4.27 (s, 2H, CH2), 7.18–7.33 (m, 4H, HAr), 7.37–7.49 (m, 2H, HAr), 7.54 (dd, J = 2.4, 8.7 Hz, 1H, HAr), 7.73 (dd, J = 5.2, 9.0 Hz, 1H, HAr), 9.17 (s, 1H, HAr). 13C NMR (50.3 MHz, CDCl3): δ = 43.3 (CH2), 110.9 (d, 2JC–F = 20.6 Hz, CHAr), 119.1 (CHAr), 121.8 (d, 2JC–F = 25.5 Hz, CHAr), 127.9 (d, 3JC–F = 8.4 Hz, Cq), 129.0 (CHAr), 129.2 (d, 3JC–F = 8.4 Hz, CHAr), 130.8 (CHAr), 132.6 (Cq), 134.0 (Cq), 138.1 (Cq), 151.3 (d,4JC–F = 5.7 Hz, CHAr), 153.2 (d,4JC–F = 2.7 Hz, CHAr), 161.0 (d, 1JC–F = 249 Hz, C–F). ESI-MS m/z (%): 272.3 (100) [M + H]+. HRMS ESI [M + H]+ calcd for C16H12ClFN 272.0637, found 227.0638.
Footnote |
| † Electronic supplementary information (ESI) available. See DOI: 10.1039/c4ob01583e |
| This journal is © The Royal Society of Chemistry 2014 |